vs
Side-by-side financial comparison of LifeMD, Inc. (LFMD) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
LifeMD, Inc. is the larger business by last-quarter revenue ($60.2M vs $38.5M, roughly 1.6× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -6.3%, a 275.0% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 13.0%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 24.8%).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
LFMD vs ORC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $60.2M | $38.5M |
| Net Profit | $-3.8M | $103.4M |
| Gross Margin | 87.7% | — |
| Operating Margin | -3.3% | — |
| Net Margin | -6.3% | 268.7% |
| Revenue YoY | 13.0% | 372.6% |
| Net Profit YoY | 18.3% | 1764.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.5M | ||
| Q3 25 | $60.2M | $26.9M | ||
| Q2 25 | $62.7M | $23.2M | ||
| Q1 25 | $64.1M | $19.7M | ||
| Q3 24 | $53.3M | $340.0K | ||
| Q2 24 | $50.7M | $-697.0K | ||
| Q1 24 | $44.1M | $-2.5M | ||
| Q4 23 | $44.9M | — |
| Q4 25 | — | $103.4M | ||
| Q3 25 | $-3.8M | $72.1M | ||
| Q2 25 | $-1.6M | $-33.6M | ||
| Q1 25 | $-183.8K | $17.1M | ||
| Q3 24 | $-4.7M | $17.3M | ||
| Q2 24 | $-6.9M | $-5.0M | ||
| Q1 24 | $-6.8M | $19.8M | ||
| Q4 23 | $-3.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | 87.7% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 86.5% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 90.1% | — | ||
| Q1 24 | 89.6% | — | ||
| Q4 23 | 88.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | -3.3% | — | ||
| Q2 25 | -0.7% | — | ||
| Q1 25 | 1.5% | — | ||
| Q3 24 | -7.5% | — | ||
| Q2 24 | -12.4% | — | ||
| Q1 24 | -14.0% | — | ||
| Q4 23 | -4.8% | — |
| Q4 25 | — | 268.7% | ||
| Q3 25 | -6.3% | 267.8% | ||
| Q2 25 | -2.6% | -145.0% | ||
| Q1 25 | -0.3% | 86.9% | ||
| Q3 24 | -8.7% | 5094.1% | ||
| Q2 24 | -13.6% | 714.3% | ||
| Q1 24 | -15.3% | -794.2% | ||
| Q4 23 | -8.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q3 24 | $-0.13 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $665.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3M | $1.4B |
| Total Assets | $66.0M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $665.9M | ||
| Q3 25 | — | $583.9M | ||
| Q2 25 | $36.2M | $440.8M | ||
| Q1 25 | $34.4M | $396.4M | ||
| Q3 24 | $37.6M | $322.1M | ||
| Q2 24 | $35.7M | $241.0M | ||
| Q1 24 | $35.1M | $190.4M | ||
| Q4 23 | $33.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.3M | $1.1B | ||
| Q2 25 | $-1.8M | $912.0M | ||
| Q1 25 | $-2.3M | $855.9M | ||
| Q3 24 | $-7.7M | $656.0M | ||
| Q2 24 | $-4.2M | $555.9M | ||
| Q1 24 | $-845.3K | $481.6M | ||
| Q4 23 | $3.5M | — |
| Q4 25 | — | $11.7B | ||
| Q3 25 | $66.0M | $9.1B | ||
| Q2 25 | $73.6M | $7.6B | ||
| Q1 25 | $73.6M | $7.3B | ||
| Q3 24 | $72.6M | $5.9B | ||
| Q2 24 | $63.8M | $4.9B | ||
| Q1 24 | $61.5M | $4.2B | ||
| Q4 23 | $58.5M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-147.1K | $120.4M |
| Free Cash FlowOCF − Capex | $-944.4K | — |
| FCF MarginFCF / Revenue | -1.6% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $120.4M | ||
| Q3 25 | $-147.1K | $28.0M | ||
| Q2 25 | $8.6M | $18.4M | ||
| Q1 25 | $3.1M | $25.8M | ||
| Q3 24 | $6.7M | $-14.8M | ||
| Q2 24 | $4.5M | $19.3M | ||
| Q1 24 | $5.2M | $45.0M | ||
| Q4 23 | $5.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-944.4K | — | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $2.9M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $5.0M | — | ||
| Q4 23 | $5.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | -1.6% | — | ||
| Q2 25 | 12.5% | — | ||
| Q1 25 | 4.6% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 7.7% | — | ||
| Q1 24 | 11.4% | — | ||
| Q4 23 | 12.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.4% | — | ||
| Q4 23 | 0.2% | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.28× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |
ORC
Segment breakdown not available.